* Lucira Health Inc LHDX.OQ reported quarterly adjusted
earnings
of 40 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 8 cents per share.
* Revenue rose 1,903.4% to $90.47 million from a year ago;
analysts expected $85.35 million.
* Lucira Health Inc's reported EPS for the quarter was 31
cents.
* The mean earnings estimate of analysts had risen by
about 73.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Lucira Health Inc shares had fallen by 30.0% this
quarter and
lost 71.0% so far this year.
* The company reported quarterly net income of $13.08
million.
* Wall Street's median 12-month price target for Lucira
Health Inc
is $7.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated May 12 at 09:46 p.m. All
figures in US dollars unless otherwise stated